Danish Construction Stock News

With a price-to-earnings (or "P/E") ratio of 17.5x Demant A/S ( CPH:DEMANT ) may be sending bearish signals at the...

Vestas Wind Systems A/S ( CPH:VWS ) shares have had a really impressive month, gaining 25% after a shaky period...

Key Insights Ambu's Annual General Meeting to take place on 3rd of December Salary of kr.8.01m is part of CEO Britt...

Amid renewed concerns over inflated AI stock valuations and receding expectations for a U.S. interest rate cut, European markets have experienced a downturn, with major indexes such as the STOXX Europe 600 and Germany's DAX seeing notable declines. In this environment of cautious sentiment, identifying undervalued stocks can present opportunities for investors seeking value in solid fundamentals and potential for growth despite broader market challenges.

Nilfisk Holding A/S ( CPH:NLFSK ) just released its latest quarterly report and things are not looking great. It was a...

The cBrain A/S ( CPH:CBRAIN ) share price has fared very poorly over the last month, falling by a substantial 28%. The...

H. Lundbeck A/S ( CPH:HLUN B ) just reported healthy earnings but the stock price didn't move much. Our analysis...

Some FLSmidth & Co. A/S ( CPH:FLS ) shareholders may be a little concerned to see that the Group Chief Executive...

Zealand Pharma (CPSE:ZEAL) just released its third quarter and nine-month results for 2025, showing a dramatic turnaround in both sales and profitability compared to the same periods last year. Investor attention is clearly focused on this shift. See our latest analysis for Zealand Pharma. After a tough start to the year, Zealand Pharma’s third quarter results have injected new optimism into the stock, with momentum clearly picking up as shown by the 24% share price return over the last 90...

Danske Bank has commenced a substantial share buy-back programme of up to DKK 5 billion, executing purchases of 211,000 shares on Nasdaq Copenhagen in the past week, which represents 1.849% of its share capital to date. Share buy-back programmes of this scale can often reflect management’s confidence in the company’s fundamentals and contribute to improving earnings per share through reduced share count. We’ll explore how Danske Bank’s active share repurchases could influence its investment...

Despite TORM plc's ( CPH:TRMD A ) recent earnings report having lackluster headline numbers, the market responded...

Shareholders appeared unconcerned with Solar A/S' ( CPH:SOLAR B ) lackluster earnings report last week. We did some...

Zealand Pharma A/S ( CPH:ZEAL ) just released its latest third-quarter results and things are looking bullish. Revenue...

It's been a pretty great week for ALK-Abelló A/S ( CPH:ALK B ) shareholders, with its shares surging 15% to kr.230 in...

Last week, you might have seen that Matas A/S ( CPH:MATAS ) released its quarterly result to the market. The early...

Wondering if Ørsted's recent turbulence means the stock is a hidden bargain or a value trap? You're not alone, and the story behind the numbers is surprisingly layered. After years of struggles, Ørsted’s stock has rebounded 5.4% over the past week and 2.7% in the last 30 days, yet it is still down a striking 63.1% year-to-date and 43.3% over the past year. Recent headlines have centered around Ørsted’s abrupt project cancellations and the company’s ongoing efforts to stabilize its offshore...

Embla Medical has opened a new prosthetic clinic in Kyiv and, at the opening, announced a three-year partnership with the Government of Iceland to deliver prosthetic care and rehabilitation to up to 1,000 Ukrainian amputees, with a total program value of US$11 million co-financed by both parties and supported by Future for Ukraine. This initiative directly addresses Ukraine’s unprecedented need for advanced prosthetic support following the war, highlighting Embla Medical’s commitment to...

FLSmidth (CPSE:FLS) shares have moved slightly higher, trading near DKK 434. Investors are likely watching recent performance and shifting sentiment as the company continues to navigate a challenging industrial landscape in Denmark this month. See our latest analysis for FLSmidth. With FLSmidth’s share price gaining over 20% year-to-date and the one-year total shareholder return above 18%, momentum has stayed firmly positive, even after a recent short-term dip. The stock’s formidable 121%...

Pandora A/S recently reported third-quarter 2025 earnings, with sales increasing to DKK 6,269 million and net income decreasing to DKK 489 million compared to the prior year, while also maintaining its 2025 guidance of 7-8% organic growth and an EBIT margin of around 24%. While quarterly profits softened, Pandora's confirmation of its full-year outlook highlights management's continued confidence in the company's growth and profitability expectations. We'll explore how the reaffirmed 2025...

Zealand Pharma reported its third quarter 2025 results, announcing sales of DKK49.57 million and a quarterly net loss of DKK404.23 million, while nine-month sales reached DKK9.15 billion with net income of DKK6.83 billion. This rapidly shifting financial picture shows a swing from net loss to substantial net income over the nine-month period, underlining the impact of recent commercial developments. We'll now consider how Zealand's dramatic year-to-date earnings turnaround may influence the...

Vestas Wind Systems A/S ( CPH:VWS ) recently posted some strong earnings, and the market responded positively. Our...

GN Store Nord (CPSE:GN) just released its latest quarterly and nine-month earnings, offering investors a look at some challenging shifts. The company reported lower sales and a sharp drop in net income compared to last year, raising questions about its operational momentum. See our latest analysis for GN Store Nord. After the earnings announcement highlighted a slide in sales and net income, GN Store Nord’s share price has been grappling with renewed skepticism, even as the company steps up...

While ISS A/S ( CPH:ISS ) might not have the largest market cap around , it saw a double-digit share price rise of over...

As the European markets face pressures from concerns over artificial intelligence stock valuations, major indices like the STOXX Europe 600 and Germany's DAX have recently seen declines. In this environment, investors may find opportunities in value stocks that are trading at estimated discounts, offering potential resilience amidst market fluctuations.